Number of shares: 107 822
Number of warrants: 0
Independent of the company’s major shareholders, the company, and its management.
Kerstin Jakobsson has extensive experience in board work and leading executive positions in international business development, marketing, and sales for life science companies, in medical technology and diagnostics. Kerstin has been CEO of Kongsberg Beam Technology AS, Ortoma AB and Medicon Village Innovation AB.
Education: Master of Science in chemistry at Lund’s University. EFL’s board education, and trained at the Board Academy.
Other current positions: Chairman of the Diagonal Bio AB (publ.). Board member of Queen Invest AB, OctaQuest AB, TeEkMi (Sustainability) Holding AB, NanoLund at Lund’s University and Stiftelsen TEM.
Number of shares: 2 100 000
Number of warrants: 0
Dependent of the company, independent of larger shareholders.
Professor of Physics at Lund University until 2016. Since 2016, Director of Biophotonics (leading a team of 40 researchers) at Tyndall National Institute, Ireland. Received the Erna Ebeling Prize from the Swedish Society for Medical Engineering and Physics in 2003. Pre-candidate for the appointment of the professorship in Biomedical Physics at the Royal Institute of Technology, Stockholm, in 1996. Co-author of over 200 articles in peer-reviewed journals.
Other current positions: Director of Biophotonics at Tyndall National Institute, Ireland. Deputy Director of the Photonics Centre IPIC, Cork, Ireland. Professor of Physics at University College Cork, Ireland.
Number of shares: 486 644
Number of warrants: 1 000 000
Independent of the company’s major shareholders, dependent on the company and its management.
Mattias Lundin has extensive experience driving growth globally with intelligent and new technology and is an international leader with 18 years of experience in the healthcare industry. He most recently came from a position as Global Sales Manager for the Swedish, world-leading medical technology company CellaVision. He has also worked as Nordic CEO, CEO of the Netherlands and VP of Commercial mature markets at ArjoHuntleigh (now Arjo) within the Getinge Group.
Education: Degree Certificate in Marketing Management at IHM Business School, Stockholm.
Other current positions: Chairman of the Board and CEO of Decon Products Holding AB. Board member of Neola Medical AB.
Number of shares: 1 270 000
Number of warrants: 0
Independent of the company’s major shareholders, the company, and its management.
Marcus Åström has over 20 years of experience in the financial industry, where he has worked globally with institutional distribution and business development. He has experience from several leading positions, including at East Capital, as responsible for business relations with leading institutions in several markets, including the Nordics and the Middle East.
Education: Master of Business Administration from Umeå University.
Other current positions: Active in his own company, Riverstream Partners, where he assists companies with, among other things, developing strategies and identifying the right partners for the company’s growth plans.
Phone: +46(0)10-204 00 15
Mail: info@lumito.se
Lumito AB (publ)
Scheelevägen 19, SE-223 63 Lund, Sweden